Imaging Modalities in Myositis: A Clinical Review.


Journal

Rheumatic diseases clinics of North America
ISSN: 1558-3163
Titre abrégé: Rheum Dis Clin North Am
Pays: United States
ID NLM: 8708093

Informations de publication

Date de publication:
Nov 2024
Historique:
medline: 17 10 2024
pubmed: 17 10 2024
entrez: 17 10 2024
Statut: ppublish

Résumé

This review highlights the key role of imaging modalities in diagnosing and managing myositis. The authors underscore MRI's superiority in identifying muscle edema and fat infiltration, marking it as essential for evaluating disease activity and damage. They also suggest ultrasound's emerging significance for diagnosis and monitoring of the disease, valued for its ease of use, and real-time capabilities. Furthermore, PET scans' unique physiologic capabilities, especially useful for malignancy detection and assessing lung disease, are emphasized. Collectively, these imaging techniques offer a tailored approach to myositis management, facilitate precise diagnosis, effective treatment planning, and disease activity monitoring, thereby enhancing patient outcomes in rheumatology practice.

Identifiants

pubmed: 39415372
pii: S0889-857X(24)00055-3
doi: 10.1016/j.rdc.2024.07.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-659

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors declare no potential conflicts of interest related to the writing and publication of this article.

Auteurs

Takeshi Yoshida (T)

Department of Rheumatology, Chikamori Hospital, Kochi, Japan; Department of Neurology, Tokushima University Hospital, Tokushima, Japan; Division of Rheumatology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Jemima Albayda (J)

Division of Rheumatology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: jalbayd1@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH